New

Corporate Venture Capital and Start-Up Innovation

How selection, ecosystems, and governance shape the innovation trade-off

8 chapters60 min total
Keywords
Corporate venture capitalStart-upsInnovationPatentsCitationsEcosystemsGovernanceAutonomyAcquisition
Overview

This series tests whether corporate venture capital (CVC) makes start-ups more innovative, separating selection from what changes after a minority investment. In OECD evidence on identified CVC programmes in Europe and North America from 2001–2022, CVC-backed start-ups already show stronger patent and funding signals; afterward, they file fewer patents but receive more citations than comparable other-VC firms. Digital intensity, geography, technological proximity, partner fit, governance, autonomy, and exit shape the trade-off. The evidence supports a conditional relationship, not a universal causal verdict, and does not capture all innovation.

Learning outcomes
  • CVC-backed start-ups already show stronger patent and funding signals; selection is not the same as treatment.
  • After first funding, the OECD event study reports fewer relative patent filings but more relative patent citations.
  • Parent digital intensity, deal geography, and technological proximity are associated with different mixes of patenting and citation outcomes.
  • The evidence is consistent with wider diffusion and exit visibility alongside narrower exploration, but the mechanisms and non-patented effects remain unresolved.
Keywords
Corporate venture capitalStart-upsInnovationPatentsCitationsEcosystemsGovernanceAutonomyAcquisition

Chapters

Preview every chapter · Unlock full text, audio, and video from chapter 4

Plans
Ch.1-3 FreeCh.4-8 Premium

FAQ

Does corporate venture capital make start-ups more innovative?

Not automatically. In the OECD analysis, CVC-backed start-ups had stronger pre-investment signals; after funding, they filed fewer patents but received more citations than comparable other-VC firms. The study does not establish a universal causal effect or capture all innovation.

Why do CVC-backed start-ups look stronger before investment?

They look stronger partly because CVC investors select for patents, larger patent stocks, funding capacity, and technological proximity to the parent. That baseline advantage cannot be credited wholly to the corporate investment.

What happens to patenting after a first CVC investment?

Relative to other-VC start-ups funded in the same year, start-ups whose first funding includes CVC show fewer log patent applications and more log patent citations. The event study finds no significant pre-treatment differences, but it remains observational.

What should founders examine before accepting CVC?

Founders should test whether promised resources are committed, IP and board rights are clear, decisions can be made quickly, and strategic autonomy and outside financing remain available. Corporate access can create value or dependence.

Does CVC investment usually lead to acquisition by the parent?

No. Among 260 acquired CVC-financed start-ups in the OECD sample, only 12—about 5%—were bought by the CVC parent; most were acquired by third parties. Acquisition does not prove improved innovation.